BioMARIC N.V. is a privately owned Belgian biotechnology company founded in August, 2001 predominantly focusing on prevention and control of infectious diseases. BioMARIC continuously maintains global collaboration with the third world scientific and medical community on projects that target to slow down the spread of infectious diseases. VISION Create maximum synergy between different stakeholders to make high quality healthcare products accessible at affordable prices in ALL countries of the world, in particular the growing economy countries and the countries located in resource-poor parts of the world. MISSION Develop next-generation healthcare products to control the spread of infectious diseases and make these products available through decentralized manufacturing in collaboration with local partners CERTIFICATION In 2019, BioMARIC was awarded the EN ISO 13485:2016 certification, which ensures that our products and services meet the stringent quality standards through an effective quality management system. BUSINESS PHILOSOPHY Depending on local market conditions, available know-how and targeted applications, BioMARIC cooperates with its partners to find the best model for cooperation and create maximum synergy to the benefit of all parties involved, including the local community. BioMARIC alliances can be based on several collaborative models: 1. Full Technology Transfer and supply of critical materials for local manufacturing at the partner’s facilities 2. Supply of selected critical detection modules developed for specific use in immunoassays 3. OEM manufacturing of the BioMARIC assay (kit) under the partner’s label